EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review

Alexandru Dinulescu iD, Alexandru-Sorin Păsărică, Mădălina Carp, Andrei Dușcă, Irina Dijmărescu iD, Mirela Luminița Pavelescu, Daniela Păcurar iD, Alexandru Ulici iD

Journal of Clinical Medicine · 13.02.2024 · 13 (4) · 1065

DOI: 10.3390/jcm13041065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.02.2024. Verfasst von Alexandru Dinulescu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departament of Pediatrics and Department of Pediatric Orthopedics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Osteogenesis imperfecta (OI) is a rare skeletal dysplasia characterized as a heterogeneous disorder group with well-defined phenotypic and genetic features that share uncommon bone fragility. The current treatment options, medical and orthopedic, are limited and not efficient enough to improve the low bone density, bone fragility, growth, and mobility of the affected individuals, creating the need for alternative therapeutic agents. (2)

Methods

We searched the medical database to find papers regarding treatments for OI other than conventional ones. We included 45 publications. (3)

Results

In reviewing the literature, eight new potential therapies for OI were identified, proving promising results in cells and animal models or in human practice, but further research is still needed. Bone marrow transplantation is a promising therapy in mice, adults, and children, decreasing the fracture rate with a beneficial effect on structural bone proprieties. Anti-RANKL antibodies generated controversial results related to the therapy schedule, from no change in the fracture rate to improvement in the bone mineral density resorption markers and bone formation, but with adverse effects related to hypercalcemia. Sclerostin inhibitors in murine models demonstrated an increase in the bone formation rate and trabecular cortical bone mass, and a few human studies showed an increase in biomarkers and BMD and the downregulation of resorption markers. Recombinant human parathormone and TGF-β generated good results in human studies by increasing BMD, depending on the type of OI. Gene therapy, 4-phenylbutiric acid, and inhibition of eIF2α phosphatase enzymes have only been studied in cell cultures and animal models, with promising results. (4)

Conclusions

This paper focuses on eight potential therapies for OI, but there is not yet enough data for a new, generally accepted treatment. Most of them showed promising results, but further research is needed, especially in the pediatric field.

Schlagwörter

Stichwörter der Autor:innen

anti-RANKL antibodiesanti-TGF-β antibodiesgene therapyinhibition of eIF2α phosphatase enzymesmesenchymal stem cellsosteogenesis imperfectarecombinant PTHsclerostin inhibition

Autor:innen und Institutionen

  • Departament of Pediatrics and Department of Pediatric Orthopedics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Departament of Pediatrics and Department of Pediatric Orthopedics, Emergency Hospital for Children ''Grigore Alexandrescu'', 011743 Bucharest, Romania.

ORCID-Profile: Alexandru Dinulescu, Irina Dijmărescu, Daniela Păcurar, Alexandru Ulici

Zitieren

APA

Dinulescu, A., Păsărică, A. S., Carp, M., Dușcă, A., Dijmărescu, I., Pavelescu, M. L., Păcurar, D., & Ulici, A. (2024). New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review. Journal of Clinical Medicine, 13(4), 1065. https://doi.org/10.3390/jcm13041065

Vancouver

Dinulescu A, Păsărică AS, Carp M, Dușcă A, Dijmărescu I, Pavelescu ML, et al. New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review. Journal of Clinical Medicine. 2024;13(4):1065. doi:10.3390/jcm13041065

BibTeX
@article{Dinulescu2024,
  author = {Dinulescu, Alexandru and Păsărică, Alexandru-Sorin and Carp, Mădălina and Dușcă, Andrei and Dijmărescu, Irina and Pavelescu, Mirela Luminița and Păcurar, Daniela and Ulici, Alexandru},
  title = {New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {1065},
  doi = {10.3390/jcm13041065}
}
Kostenlos starten →